Clinical Trial: A Study to Identify and Characterize LAL-D Patients in High-risk Populations
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: A Study to Identify the Frequency of Lysosomal Acid Lipase Deficiency in At-Risk Patient Populations
Brief Summary: The objective of this study is to determine the frequency of Lysosomal Acid Lipase Deficiency (LAL D) by lysosomal acid lipase (LAL) enzyme activity assay in patients who are considered to be at risk.
Detailed Summary:
Sponsor: Alexion Pharmaceuticals
Current Primary Outcome: LAL D frequency based on LAL enzyme assay. [ Time Frame: approximately 1 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Alexion Pharmaceuticals
Dates:
Date Received: January 19, 2015
Date Started: December 2014
Date Completion:
Last Updated: May 23, 2016
Last Verified: May 2016